These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34018996)

  • 1. Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma.
    Shao CC; Zhao F; Yu YF; Zhu LL; Pang GD
    Chin Med J (Engl); 2021 Apr; 134(10):1181-1190. PubMed ID: 34018996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.
    Zhao F; Pang G; Li X; Yang S; Zhong H
    Sci Rep; 2021 Nov; 11(1):23163. PubMed ID: 34848818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.
    Pang G; Shao C; Lv Y; Zhao F
    Medicine (Baltimore); 2021 Apr; 100(16):e25627. PubMed ID: 33879737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion parameters of triphasic computed tomography hold preoperative prediction value for microvascular invasion in hepatocellular carcinoma.
    Zhang L; Pang G; Zhang J; Yuan Z
    Sci Rep; 2023 May; 13(1):8629. PubMed ID: 37244941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
    Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
    Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
    Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
    Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
    Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MSCT perfusion imaging and its correlation with perfusion parameters, survivin expression, MVD, and pathologic grade in hepatocellular carcinomas].
    Long X; Cao J; Shi L; Li W; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1096-102. PubMed ID: 19952399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
    Nakachi K; Tamai H; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    Cancer Imaging; 2014 Apr; 14(1):7. PubMed ID: 25608454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH; Lee JM; Klotz E; Han JK
    Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
    Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
    Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
    Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
    Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.
    Nishie A; Yoshimitsu K; Okamoto D; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Shirabe K; Fujita N; Honda H
    Jpn J Radiol; 2013 Feb; 31(2):89-98. PubMed ID: 23070581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma Screening With Computed Tomography Using the Arterial Enhancement Fraction With Radiologic-Pathologic Correlation.
    Huber AT; Schuster F; Ebner L; Bütikofer Y; Ott D; Leidolt L; Jöres A; Montani M; Heverhagen J; Christe A
    Invest Radiol; 2016 Jan; 51(1):25-32. PubMed ID: 26619283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.
    Li JP; Feng GL; Li DQ; Wang HB; Zhao DL; Wan Y; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):612-618. PubMed ID: 27919850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.